Related references
Note: Only part of the references are listed.PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes
Joji Nagasaki et al.
CELL REPORTS (2022)
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
McLane J. Watson et al.
NATURE (2021)
Glucose makes Treg lose their temper
Matteo Villa et al.
CANCER CELL (2021)
Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition
Catherine Vander Linden et al.
CELL REPORTS (2021)
Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS
Jinhua Li et al.
EMBO REPORTS (2020)
Histone Lactylation: A New Role for Glucose Metabolism
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
Lactate as a fulcrum of metabolism
George A. Brooks
REDOX BIOLOGY (2020)
Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer
Lorenzo Castagnoli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Metabolic regulation of gene expression by histone lactylation
Di Zhang et al.
NATURE (2019)
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
Reem Saleh et al.
VACCINES (2019)
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Xuhao Ni et al.
CANCER DISCOVERY (2018)
Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome
Eleonora Gambineri et al.
FRONTIERS IN IMMUNOLOGY (2018)
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
Frederick Arce Vargas et al.
IMMUNITY (2017)
Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways
Anthony Joetham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Lactic Acid: No Longer an Inert and End-Product of Glycolysis
Shiren Sun et al.
PHYSIOLOGY (2017)
Metabolic Interactions in the Tumor Microenvironment
Costas A. Lyssiotis et al.
TRENDS IN CELL BIOLOGY (2017)
The regulation of immune tolerance by FOXP3
Ling Lu et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Metabolism shapes the tumor microenvironment
Miguel Reina-Campos et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Alessia Angelin et al.
CELL METABOLISM (2017)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years
Sebastian Blatt et al.
CLINICAL ORAL INVESTIGATIONS (2016)
FOXP3+ regulatory T cells and their functional regulation
Zhiyuan Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
iTreg induced from CD39+ naive T cells demonstrate enhanced proliferate and suppressive ability
Yunjie Lu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
In Vivo-Generated Antigen-Specific Regulatory T Cells Treat Autoimmunity Without Compromising Antibacterial Immune Response
Shimpei Kasagi et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
Pengyuan Yang et al.
CANCER CELL (2012)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Marcin Kortylewski et al.
CANCER CELL (2009)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Lactate: Mirror and motor of tumor malignancy
S Walenta et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+ CD25+ T cells
GL Stephens et al.
JOURNAL OF IMMUNOLOGY (2004)
Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance
J Shimizu et al.
NATURE IMMUNOLOGY (2002)
CD4+CD25+ immunoregulatory T cells:: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor
RS McHugh et al.
IMMUNITY (2002)
Share Paper
